Literature DB >> 22783258

TLR signaling in mast cells: common and unique features.

Hilary Sandig1, Silvia Bulfone-Paus.   

Abstract

In addition to the well known role of mast cells in immunity to multi-cellular parasites and in the pathogenesis of allergy and asthma, the importance of mast cells in the immune defense against bacteria and viruses is increasingly being recognized. Their location in the skin, gut, and airways puts mast cells in an ideal location to encounter and respond to pathogens, and in order to perform this function, these cells express a variety of pattern recognition receptors, including Toll-like receptors (TLRs). Mast cells respond to TLR ligands by secreting cytokines, chemokines, and lipid mediators, and some studies have found that TLR ligands can also cause degranulation, although this finding is contentious. In addition, stimulation via TLR ligands can synergize with signaling via the FcεRI, potentially enhancing the response of the cells to antigen in vivo. A great deal is now known about TLR signaling pathways. Some features of these pathways are cell type-specific, however, and work is under way to fully elucidate the TLR signaling cascades in the mast cell. Already, some interesting differences have been identified. This review aims to address what is known about the responses of mast cells to TLR ligands and the signaling pathways involved. Given the location of mast cells at sites exposed to the environment, the response of these cells to TLR ligands must be carefully regulated. The known mechanisms behind this regulation are also reviewed here.

Entities:  

Keywords:  TLRs; cytokine; innate; mast cells; review; signaling

Year:  2012        PMID: 22783258      PMCID: PMC3389341          DOI: 10.3389/fimmu.2012.00185

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  73 in total

1.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Christine H Song; Gerald Krystal
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

Review 2.  Mast-cell responses to pathogens.

Authors:  Jean S Marshall
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

Review 3.  Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.

Authors:  Toshiaki Kawakami; Jiro Kitaura
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

4.  Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12.

Authors:  Jessica A Hamerman; Nadia K Tchao; Clifford A Lowell; Lewis L Lanier
Journal:  Nat Immunol       Date:  2005-05-15       Impact factor: 25.606

5.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation.

Authors:  Ashley Mansell; Rosealee Smith; Sarah L Doyle; Pearl Gray; Jennifer E Fenner; Peter J Crack; Sandra E Nicholson; Douglas J Hilton; Luke A J O'Neill; Paul J Hertzog
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

6.  FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells.

Authors:  Huihong Qiao; Marcus V Andrade; Felipe A Lisboa; Katrina Morgan; Michael A Beaven
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

7.  CD14 is required for MyD88-independent LPS signaling.

Authors:  Zhengfan Jiang; Philippe Georgel; Xin Du; Louis Shamel; Sosathya Sovath; Suzanne Mudd; Michael Huber; Christoph Kalis; Simone Keck; Chris Galanos; Marina Freudenberg; Bruce Beutler
Journal:  Nat Immunol       Date:  2005-05-15       Impact factor: 25.606

8.  Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.

Authors:  Marianna Kulka; Lena Alexopoulou; Richard A Flavell; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

9.  Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI.

Authors:  Shigeru Okumura; Jun-ichi Kashiwakura; Hisashi Tomita; Kenji Matsumoto; Toshiharu Nakajima; Hirohisa Saito; Yoshimichi Okayama
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

10.  Subcellular localization of Toll-like receptor 3 in human dendritic cells.

Authors:  Misako Matsumoto; Kenji Funami; Masako Tanabe; Hiroyuki Oshiumi; Masashi Shingai; Yoshiyuki Seto; Akitsugu Yamamoto; Tsukasa Seya
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

View more
  83 in total

Review 1.  Signal transduction and chemotaxis in mast cells.

Authors:  Petr Draber; Ivana Halova; Iva Polakovicova; Toshiaki Kawakami
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

2.  Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Marshall V Williams PhD; Brandon Cox; William P Lafuse PhD; Maria Eugenia Ariza
Journal:  Clin Ther       Date:  2019-04-28       Impact factor: 3.393

Review 3.  Innate immunity in disease.

Authors:  David E Elliott; Sana S Siddique; Joel V Weinstock
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-12       Impact factor: 11.382

4.  Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms.

Authors:  Marc Becker; Niels A W Lemmermann; Stefan Ebert; Pamela Baars; Angelique Renzaho; Jürgen Podlech; Michael Stassen; Matthias J Reddehase
Journal:  Cell Mol Immunol       Date:  2014-08-25       Impact factor: 11.530

5.  Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation.

Authors:  F Guzmán-Mejía; C López-Rubalcava; C González-Espinosa
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-18       Impact factor: 4.147

Review 6.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

7.  Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.

Authors:  Kshitij Gupta; Chizobam Idahosa; Saptarshi Roy; Donguk Lee; Hariharan Subramanian; Anuradha Dhingra; Kathleen Boesze-Battaglia; Jonathan Korostoff; Hydar Ali
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

8.  Effect of TNF-α inhibitors on transcriptional levels of pro-inflammatory interleukin-33 and Toll-like receptors-2 and -9 in psoriatic plaques.

Authors:  Dimitra P Vageli; Aikaterini Exarchou; Efterpi Zafiriou; Panagiotis G Doukas; Sotirios Doukas; Angeliki Roussaki-Schulze
Journal:  Exp Ther Med       Date:  2015-08-18       Impact factor: 2.447

9.  Inhibitory effects of methamphetamine on mast cell activation and cytokine/chemokine production stimulated by lipopolysaccharide in C57BL/6J mice.

Authors:  Li Xue; Yan Geng; Ming Li; Yao-Feng Jin; Hui-Xun Ren; Xia Li; Feng Wu; Biao Wang; Wei-Ying Cheng; Teng Chen; Yan-Jiong Chen
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

10.  LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP.

Authors:  Thomas Hochdörfer; Christopher Tiedje; Deborah J Stumpo; Perry J Blackshear; Matthias Gaestel; Michael Huber
Journal:  Cell Signal       Date:  2013-03-14       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.